Last Price$4.02NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/10/20
NASDAQ 15-minute delayed Bid/Ask Quotes
Today's Change0(0.00%)
Bid (Size)$3.98 (21)
Ask (Size)$3.99 (14)
Day Low / HighN/A - N/A
Volume9.6 M

Insider Trends: Insider Purchase Continues OPKO Health Positive Trend

6:10AM ET 10/31/2019 MT Newswires
On Oct 30, 2019, Dr Phillip Frost, 10% Owner, Director and CEO & Chairman, bought 200,000 shares in OPKO Health (OPK) for $288,533. Dr Frost, following the transactions delineated in the Form 4 SEC filing, controls 220,271,633 shares of the company of which 3,068,951 shares are held directly and 217,202,682 shares are owned indirectly. The market value of the direct and indirect holdings, based on the prior-day closing price, is approximately $322 million.

During the most recent 90-day period, previous to the date of this filing, there has been one additional insider transaction which has resulted in the acquisition of 200,000 of company shares. Relative to the preceding 90-day window of time, there were 35 transactions from 7 insiders that resulted in the net acquisition of 4,405,250 shares.

This is lower than the average level of insider transactions in the 150-company Pharmaceuticals peer group over the last 90-day period. Activity in the peer group averaged 39.7 transactions per company, and disposition of 6,418 shares on average.

SEC Story Link http://www.sec.gov/Archives/edgar/data/944809/000120919119054580/xslF345X03/doc4.xml